Abstract
Prostate cancer (PCa) is the most common internal malignancy and the third most frequent cause of cancer death in men. It is estimated that in each week of 2009 over 490 Canadian men were diagnosed with PCa, and 85 will have died from the disease. The introduction of PSA (prostate-specific antigen) screening tests has contributed in part, to men being diagnosed and treated at an early stage. Chemoprevention is a strategy whereby patients are administered drugs, vitamins, or other agents to prevent/reduce the risk of cancer progression and/ or delay the development of its recurrence thereby decreasing patient morbidity and mortality. PCa has a long latency period, thereby offering plenty of opportunity to intervene through the implementation of chemopreventive therapies. A large body of epidemiologic evidence, together with published data from in vivo and in vitro studies, strongly supports relationships between dietary constituents and the risk of prostate cancer. This article aims to review the diverse aspects of chemoprevention including the benefit of both macro- and micronutrients that have been implicated in prostate cancer prevention. In addition we discuss perspectives on the putative mechanisms of selected chemopreventive agents and highlight several clinical studies using specific chemopreventive interventions.
Keywords: Prostate cancer, diet, micronutrients, flavonoids, in vivo, clinical trials.
Current Cancer Therapy Reviews
Title:Dietary Agents for Prostate Cancer Chemoprevention: An Overview
Volume: 6 Issue: 4
Author(s): Natalie A. Venier, Laurence H. Klotz, Neil E. Fleshner and Vasundara Venkateswaran
Affiliation:
Keywords: Prostate cancer, diet, micronutrients, flavonoids, in vivo, clinical trials.
Abstract: Prostate cancer (PCa) is the most common internal malignancy and the third most frequent cause of cancer death in men. It is estimated that in each week of 2009 over 490 Canadian men were diagnosed with PCa, and 85 will have died from the disease. The introduction of PSA (prostate-specific antigen) screening tests has contributed in part, to men being diagnosed and treated at an early stage. Chemoprevention is a strategy whereby patients are administered drugs, vitamins, or other agents to prevent/reduce the risk of cancer progression and/ or delay the development of its recurrence thereby decreasing patient morbidity and mortality. PCa has a long latency period, thereby offering plenty of opportunity to intervene through the implementation of chemopreventive therapies. A large body of epidemiologic evidence, together with published data from in vivo and in vitro studies, strongly supports relationships between dietary constituents and the risk of prostate cancer. This article aims to review the diverse aspects of chemoprevention including the benefit of both macro- and micronutrients that have been implicated in prostate cancer prevention. In addition we discuss perspectives on the putative mechanisms of selected chemopreventive agents and highlight several clinical studies using specific chemopreventive interventions.
Export Options
About this article
Cite this article as:
A. Venier Natalie, H. Klotz Laurence, E. Fleshner Neil and Venkateswaran Vasundara, Dietary Agents for Prostate Cancer Chemoprevention: An Overview, Current Cancer Therapy Reviews 2010; 6 (4) . https://dx.doi.org/10.2174/157339410793358093
DOI https://dx.doi.org/10.2174/157339410793358093 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Emerging Roles of Cysteine Cathepsins in Disease and their Potential as Drug Targets
Current Pharmaceutical Design Melatonin, A Natural Programmed Cell Death Inducer in Cancer
Current Medicinal Chemistry Chebulagic Acid Synergizes the Cytotoxicity of Doxorubicin in Human Hepatocellular Carcinoma Through COX-2 Dependant Modulation of MDR-1
Medicinal Chemistry Depression in Older Persons with Mobility Limitations
Current Pharmaceutical Design Recent Studies on HDAC Inhibitors Acting against Prostate Cancer
Current Enzyme Inhibition Synthesis, Biological and Computational Evaluation of Novel 2,3-dihydro-2-aryl-4-(4- isobutylphenyl)-1,5-benzothiazepine Derivatives as Anticancer and Anti-EGFR Tyrosine Kinase Agents
Anti-Cancer Agents in Medicinal Chemistry Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
Current Drug Targets Low-Density Lipoprotein Cholesterol (LDL-C): How Low?
Current Vascular Pharmacology Breast Cancer: Current Developments in Molecular Approaches to Diagnosis and Treatment
Recent Patents on Anti-Cancer Drug Discovery Subject Index To Volume 5
CNS & Neurological Disorders - Drug Targets Improvement of Tumor Localization of Photosensitizers for Photodynamic Therapy and Its Application for Tumor Diagnosis
Current Topics in Medicinal Chemistry DNA Microarrays: Perspectives for Hypothesis-Driven Transcriptome Research and for Clinical Applications
Current Genomics Targetin g Human Tel omerase by Antisens e Oligonucleotides and Ribozymes
Current Medicinal Chemistry - Anti-Cancer Agents Retinoblastoma Regulatory Pathway in Lung Cancer
Current Molecular Medicine Chemotherapy for Prostate Cancer
Current Pharmaceutical Design Antineoplastic Activity, Structural Modification, Synthesis and Structure-activity Relationship of Dammarane-type Ginsenosides: An Overview
Current Organic Chemistry Computational Protein Design: A Novel Path to Future Protein Drugs
Current Pharmaceutical Design On the Design of Broad Based Screening Assays to Identify Potential Pharmacological Chaperones of Protein Misfolding Diseases
Current Topics in Medicinal Chemistry Distinctive Cellular Roles for Novel Protein Kinase C Isoenzymes
Current Pharmaceutical Design Exploration of Metastasis-related Proteins as Biomarkers and Therapeutic Targets in the Treatment of Head and Neck Cancer
Current Cancer Drug Targets